Sungwon Lim, PhD
CEO & Co-founder
ImpriMed, Inc
ImpriMed CEO and Co-Founder Sungwon Lim is a bioengineer and entrepreneur with 20 years of collective experience in academia and biotech companies. He received his Ph.D. degree in Bioengineering from Stanford University and a Master’s degree in Translational Medicine from the UC Berkeley–UCSF Joint Bioengineering Program. His background in the lengthy process of developing new cancer therapeutics gave him the idea to more effectively target cancer with available therapeutics to help patients who need treatment today.
Dr. Lim has given presentations at the American Society of Hematology, Precision Medicine World Conference, Veterinary Cancer Society, and World Veterinary Cancer Congress. He has received Life Science Voice’s Top Industry Leaders Award and the 40 Under 40 in Cancer Award.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}